State College, Pennsylvania, March 15, 2011 - Diagnostics Plus Announces New Corporate Identity and Name Changes for Its Two Operating Divisions

New operating division names more accurately reflect its longstanding industry focus and expertise.

Dr. Paul Weener, CEO of Diagnostics Plus, today announced the launch of its new corporate identity, IntelliQ Research and Strategy, Inc., as well as IntelliQ B2B and IntelliQ Health as the new names for its two operating divisions, Diagnostics Plus and Cooper Research.

These name changes are the culmination of an integration process that started in 2010 when Cooper Research, a leading healthcare research and strategy firm merged with Diagnostics Plus, a State College, Pennsylvania based market research firm specializing in Business-to-Business markets.  “While both firms will continue to operate as separate divisions and continue to focus on their respective industry sectors, the new names will more accurately reflect their respective longstanding industry focus and expertise and will also be aligned with our new corporate identity,” explained Dr. Miller, CEO of Cooper Research.

“This represents a major milestone for our organization,” added Dr. Paul Weener, founder of Diagnostics Plus. “We have emerged from the integration of Cooper Research and Diagnostics Plus as a stronger and significantly more capable and efficient organization that will continue to provide the superior and specialized market research and client services our customers have come to rely on over the years.“

Beginning today, the company has launched a new corporate website, as well as new divisional sites, and  Effective immediately, all future business activity will be conducted using the new names.

Diagnostics Plus, founded in 1987 as a full service market research and intelligence firm, has specialized in helping organizations in the manufacturing, transportation and education sectors worldwide fulfill their information and planning needs by transforming data into meaningful information and insights, and assisting companies in making data-informed decisions.

For nearly 30 years, Cooper Research has been focused exclusively on providing market intelligence, research and insights to the healthcare industry with extensive experience across the entire spectrum of healthcare and a portfolio of thousands of studies across North America as well as international markets for pharmaceuticals, insurance/health plans, providers, medical devices and information technology companies, as well as healthcare related non-profit organizations.

Collectively, IntelliQ Research and Strategy, Inc. has significantly expanded capabilities including a highly professional data collection center (phone, Internet, mail), sophisticated data processing and marketing sciences capabilities, strong international capabilities in Europe, South America, and Asia Pacific, and deep industry knowledge and expertise in the healthcare and a variety of B2B sectors.  For more information about IntelliQ Research and Strategy, please visit

Paul Weener, Ph.D.
120 Foster Ave.
State College, Pennsylvania, 16801